Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS

NCT03905707 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Short Bowel Syndrome

Interventions

DRUG: glepaglutide

Sponsor

Zealand Pharma